ONO PHARMACEUTICAL CO.,LTD.

4528

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-31FY2027 Q1

Revenue

5044.1100M JPY

YoY +1.5%

Operating Income

306.5100M JPY

YoY +39.4%

Net Income

762.5100M JPY

YoY +77.6%

EPS

51.4JPY

YoY +36.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

5157.9億円

3868.4億円

2578.9億円

1289.5億円

Rev: 3613.6億円Op: 1032億円NI: 805.2億円

Rev: 4471.9億円Op: 1419.6億円NI: 1127.2億円

Rev: 5026.7億円Op: 1599.3億円NI: 1279.8億円

Rev: 4868.7億円Op: 597.5億円NI: 500.5億円

Rev: 5157.9億円Op: 922.4億円NI: 697.7億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income34%

Revenue Progress1161.600M

Revenue Forecast455000M

Net Income Progress241.500M

Net Income Forecast71000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan